Discovery and Analytical Validation of a Vocal Biomarker to Monitor Anosmia and Ageusia in Patients With COVID-19: Cross-sectional Study

BACKGROUND: The COVID-19 disease has multiple symptoms, with anosmia and ageusia being the most prevalent, varying from 75% to 95% and from 50% to 80% of infected patients, respectively. An automatic assessment tool for these symptoms will help monitor the disease in a fast and noninvasive manner. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Higa, Eduardo, Elbéji, Abir, Zhang, Lu, Fischer, Aurélie, Aguayo, Gloria A, Nazarov, Petr V, Fagherazzi, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645416/
https://www.ncbi.nlm.nih.gov/pubmed/36265042
http://dx.doi.org/10.2196/35622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645416/
https://www.ncbi.nlm.nih.gov/pubmed/36265042
http://dx.doi.org/10.2196/35622

Ejemplares similares